Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7297 p542
1 May 2004

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Indemnity insurance
· CPD
· Drug nomenclature
· NHS pension scheme
· Ampoule labelling
· The profession
· Electronic prescribing
· Canvassing
· The Society


Letters to the Editor

Electronic prescribing

It is what ETP can deliver that is important

From Mr S. F. Freeborn, MRPharmS

As a major supplier of pharmacy, electronic prescribing, electronic administration recording and integrated clinical software solutions, I would like to offer a view on the Broad spectrum article, “Is electronic prescribing a Holy Grail?” (PJ, 3 April, p412).

History has always concentrated on the search for the Holy Grail and not what it might offer, as if the object were more important than the benefits that could be produced by the find. For me, the Holy Grail is not electronic prescribing, which several companies, including ourselves, have experience in implementing. The Holy Grail is the reduction in patient risk that will ensue from its introduction. The real issue about electronic prescribing is that it is not an end in itself but it is what benefits it can bring.

Electronic prescribing forms only part of what is being termed “e-medicines management”, which encompasses the whole picture of using technology to support the process of management of medicines across all of the boundaries of health care. The National Programme for Information Technology (NPfIT) agenda will facilitate this evolution, but only if pharmacy is heavily involved in the deliverables. I would encourage all pharmacists, especially those who manage services, to involve themselves in understanding the ramifications of NPfIT to their future service delivery.

Stephen Freeborn
Pharmacy Division,
ASC Computer Software

Send your letter to The Editor

Previous Topic (The profession)
Next Topic (Canvassing)

Back to Top


©The Pharmaceutical Journal